SL Science Holding EBIT

As of the most recent data (March 2026), SLBT shows a EBIT of $-1.1M. That is below the Healthcare sector average of $130B. Scroll down for historical charts and peer comparison views.

The Healthcare sector average EBIT is about $130B. SL Science Holding is at $-1.1M, which is lower that average. That is roughly 100.0% below the sector mean. Use the comparison chart on this page to see how SLBT stacks up against individual peers as well.

Tracking SLBT's ebit over time shows whether SL Science Holding is scaling, shrinking, or reshaping that part of the business. The current reading is $-1.1M Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this ebit page, Stockcircle has SL Science Holding's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect EBIT (currently $-1.1M) with ownership activity and broader fundamentals.

The Healthcare average EBIT is about $130B, while SLBT is at $-1.1M. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.